Zhang, J., Wang, L., Zhang, S., Cao, R., Zhao, Y., Zhao, Y., . . . Guo, Z. (2024). Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients. BMC Cancer, 24(1), . https://doi.org/10.1186/s12885-024-11999-z
Chicago-referens (17:e uppl.)Zhang, Jingjing, Lei Wang, Shasha Zhang, Ruijie Cao, Yufei Zhao, Yue Zhao, Yanrong Song, och Zhanjun Guo. "Alpha-fetoprotein Predicts the Treatment Efficacy of Immune Checkpoint Inhibitors for Gastric Cancer Patients." BMC Cancer 24, no. 1 (2024). https://doi.org/10.1186/s12885-024-11999-z.
MLA-referens (9:e uppl.)Zhang, Jingjing, et al. "Alpha-fetoprotein Predicts the Treatment Efficacy of Immune Checkpoint Inhibitors for Gastric Cancer Patients." BMC Cancer, vol. 24, no. 1, 2024, https://doi.org/10.1186/s12885-024-11999-z.
